Subscribe
m-a-istock-523159870_in-focus
in-focus / iStockphoto.com
13 June 2018Americas

Life sciences analytics providers combine in $195m deal

Clinical technology company Medidata has bought Shyft Analytics, a cloud data analytics platform, for $195 million.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.
Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.
Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.

More on this story

Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.
Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages